Clean Science Q1 FY27 call: record sales, HALS ramps up, new deals

Clean Science posted record consolidated sales of INR 264 crores in Q1 FY27. Standalone revenue grew 5 percent sequentially to INR 203 crores; EBITDA margin at 43 percent, PAT margin at 36 percent. Y-o-Y sales fell 6 percent on raw material supply issues and shipping delays. HALS now 22 percent of sales, targeting INR 250-300 crores annualized. New partnership with Swiss firm Geneus Chem for advanced NOR HALS could add INR 300-350 crores over 4 years. 5-year exclusive supply deal signed with Kemin (20-40 percent offtake increase). Management guides EBITDA margins to keep improving with higher-grade mix.